期刊
MOLECULAR PHARMACEUTICS
卷 10, 期 6, 页码 2183-2189出版社
AMER CHEMICAL SOC
DOI: 10.1021/mp300559v
关键词
biodegradation; degradation; biodistribution; drug delivery; liver
资金
- Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences
- Provost's Office, Wayne State University
The biodegradable polymer poly(lactic-co-glycolic) acid (PLGA) has been extensively utilized and investigated as a drug delivery system. Although in vivo biodegradation (at specific administration sites only) of PLGA-based drug delivery constructs, such as foams and microparticles, has been studied, quantitative in vivo biodegradation of distributed polymer nanoparticles has not been accomplished and is quintessential for designing formulations to achieve desired pharmacokinetic, properties of a drug in a, target tissue. We determined the in vivo degradation kinetics of PLGA nanoparticles, of two sizes, distributed in liver, spleen, and lungs following intravenous administration. In addition, we simultaneously determined the amount of polymer in tissues. Nanoparticle degradation in vitro and in vivo appears to be a first-order process, and useful correlations were obtained between in vitro and in vivo tissue degradation of the nanoparticles. The ability to detect in vivo degradation and biodistribution of polymer nanoparticles is a significant milestone for the rational design of degradable nanoparticle-based drug delivery systems capable of delivering the therapeutic agent in a closely predictable manner to target tissue.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据